Articles tagged with Serotonin Receptors
A new study emphasizes the importance of accessible maternity and psychiatric care for pregnant women suffering from major depressive disorder. The research highlights the need to balance treatment benefits with potential risks associated with SSRI exposure, suggesting a structured approach to decision-making.
Researchers at the University of Missouri have identified a small molecule drug that targets a specific serotonin receptor, showing promise as a treatment for sarcopenia. The study suggests that this neurotherapeutic can improve muscle strength by activating motor neurons to fire more effectively.
Researchers found that serotonin release scales with the value of rewards, indicating its role in monitoring reward quality. The study used a new biosensor to measure serotonin levels in mice receiving varied concentrations of evaporated milk as rewards.
Researchers found that SSRI antidepressants improve cognitive functions like verbal memory by reducing a specific serotonin receptor. The study suggests that stimulating this receptor may be a promising target for optimizing antidepressant treatment outcomes.
Researchers have discovered a stable intermediate form of the serotonin-gated 5-HT3A receptor, which could serve as a new drug target for psychiatric and gastrointestinal disorders. The study provides insights into the synthesis and assembly of membrane proteins.
Researchers have shed light on the mechanisms by which psychedelic drugs, such as LSD and psilocybin, bind to and activate serotonin receptors. The study highlights the potential therapeutic benefits of these compounds in treating depression and anxiety disorders.
A new study identifies multiple emotion regulation systems in the human brain, providing targets for therapy. The research reveals that regions in the anterior prefrontal cortex and higher-level cortical hierarchies are involved in emotion regulation.
A new study found that the serotonin booster prucalopride increased functional brain connectivity in healthy adults, particularly between cognitive networks. The results suggest that prucalopride may improve cognitive function and have therapeutic potential for depression patients.
Researchers found altered serotonin 2A/C receptor binding in brain stems of infants who died from SIDS, suggesting a biological basis for the condition. The study suggests that specific combinations of genetic vulnerability, external stressors, and critical developmental periods may contribute to SIDS.
Researchers at University of Southern Denmark discovered that psilocin binds stronger than serotonin to a specific receptor, leading to antidepressant effects. The study's findings have potential implications for treating conditions like severe depression and substance addiction.
Researchers discovered a significant increase in serotonin transporter density in the midbrain of patients with PMDD during the periovulatory phase, which was associated with increased depressed mood. The study suggests that taking SSRIs at specific times during the menstrual cycle may help target these changes and alleviate symptoms.
Researchers found reduced serotonin release capacity in individuals with depression, suggesting a blunted serotonin system. The study used novel imaging techniques to measure serotonin levels in the brain, providing crucial insights into the pathology of depression.
A comprehensive review of research on serotonin and depression found no link between the two, contradicting long-held theories. The study suggests that antidepressants' effectiveness may be due to managing stressful life events rather than correcting chemical imbalances.
Scientists made a breakthrough in understanding the structure and function of serotonin receptors, revealing the molecular mechanism of selective coupling with G-proteins. The study provides insights into ligand recognition and could lead to rational structure-based drug design for treating diseases linked to serotonin imbalance.
Scientists have discovered the first X-ray crystallography structure of LSD bound to its target in the brain, revealing how it induces hallucinogenic effects. The study also uncovers images of a prototypical hallucinogen coupled with the entire serotonin receptor complex.
A study modelled psilocybin's interaction with the brain, explaining its therapeutic effects on depression, anxiety and addiction. The research integrated data from various imaging techniques to reveal the stimulation of serotonin receptors 5-HT2A involved in psychoactive modulation.
Researchers at Case Western Reserve University School of Medicine used high-tech microscopes to view serotonin activating its receptor for the first time. The study highlights distinct conformations of the receptor that could lead to more precise drugs targeting specific regions or functions of serotonin receptors.
The ESRF cryo-electron microscope has achieved significant results in its first year, publishing research on the 5-HT3 serotonin receptor. The study revealed the receptor's activation cycle and binding pockets, providing crucial information for developing antinausea drugs.
A team of researchers from Case Western Reserve University School of Medicine has used cryo-electron microscopy to capture the structure of full-length serotonin receptors for the first time. This breakthrough provides valuable insights into molecular binding sites that could lead to more precise drug design and targeted therapies.
A recent paper explores how protein CK2 plays a key role in treating major depressive disorder. Manipulation of CK2 in the brain decreases depressive and anxious states through the 5-HT4 receptor.
For the first time, researchers at UNC School of Medicine have discovered precisely what LSD looks like in its active state when attached to a human serotonin receptor. This breakthrough reveals that the psychoactive effects of LSD last for so long because part of the receptor folds over the drug molecule, locking it in place.
A study in the American Journal of Pathology finds that serotonin deficiency is associated with worse rheumatoid arthritis (RA) symptoms and pathology in mice. Serotonin or its agonists can reduce RA effects, suggesting a new therapeutic target for this debilitating disease.
Researchers have uncovered a significant relationship between a chemical transmitting brain signals and genetic mutations in individuals with autism spectrum disorder. Targeting a specific serotonin receptor, 5-HT2cR, can reverse social deficits in mouse models of the autism risk gene Pten.
A study published in PLOS Pathogens has identified a key player in the movement of schistosome parasites: serotonin receptors. The discovery opens up new avenues for developing targeted treatments against this parasitic flatworm, which affects millions worldwide and kills an estimated 250,000 people annually.
A research team has decoded the molecular structure of the serotonin receptor at room temperature for the first time, revealing its dynamics and giving a more realistic picture of its physiological function. This breakthrough could lead to better-designed drugs and new ways to investigate large biomolecules.
The study reveals that JC polyomavirus uses specific serotonin receptors to gain entry into cells, contrary to initial hypotheses. This discovery could lead to improved treatment options for patients with PML by informing how existing drugs work.
Researchers have determined the high-resolution atomic structures of two human serotonin receptor types, shedding light on why certain drugs interact with these receptors in complex and sometimes harmful ways. The study's findings offer valuable insights into designing safer and more effective medicines.
Researchers identified a key receptor in the brain that influences serotonin-related antidepressants, providing a potential new target for treatment. The discovery could lead to more effective and targeted treatments for depression and anxiety with fewer side effects.
Researchers at the University of Alberta have discovered a natural self-repair mechanism that kick-starts after spinal-cord injuries, offering promising new treatments. Serotonin receptors remain active after injury, but are permanently turned on, contributing to muscle spasms; blocking these receptors could help alleviate symptoms.
A study from Columbia University Medical Center found that an excess of one type of serotonin receptor in the brain's center may cause antidepressants to fail for half of patients. Researchers created a mouse model with high and low receptor levels, showing that reducing receptors can transform non-responders into responders.
A study published in Human Molecular Genetics found an association between a functional variant of the serotonin receptor-type 3E gene and diarrhea-predominant irritable bowel syndrome. This correlation could lead to the development of specific medications for certain genetic mutations in patients.
Researchers have discovered a new class of antidepressants that work by directly enhancing nerve impulses of serotonin neurons. The compounds, RS 67333 and prucalopride, target serotonin type-4 receptors and have been shown to reduce symptoms of depression in rats after just three days of treatment.
A study published in Nature found that mice without a serotonin receptor gene exhibit anxiety-like behaviors, indicating the gene plays a crucial role in regulating emotional circuitry. The research suggests that anxiety may be laid down during early development, and that adult brains without the serotonin receptor create normal behavior.
Researchers created genetically altered mice that exhibit anxiety to study the serotonin system's contribution to anxiety and depression. The model could help develop more refined targets for psychiatric drugs and provide insights into inherited personality disorders.
A study examining brain tissue from suicides and controls reveals higher serotonin receptor binding in certain areas, particularly those associated with violent deaths. The findings suggest a potential link between altered serotonin function and suicidal behavior.